Titre :
  • Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.
Auteur : Awada, Ahmad ; Gil, Thierry ; Sales, Francois ; Dubuisson, Michel ; Vereecken, P ; Klastersky, Jean ; Moerman, Carine ; De Valeriola, Dominique ; Piccart-Gebhart, Martine
Informations sur la publication : Anti-cancer drugs, 15, 5, (page 499-502)
Statut de publication : Publié, 2004-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Dacarbazine -- administration & dosage
Dacarbazine -- analogs & derivatives
Doxorubicin -- administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Liposomes
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms -- drug therapy
Neutropenia -- chemically induced
Stomatitis -- chemically induced
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase I
Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0959-4973 
info:pii/00001813-200406000-00012
info:pmid/15166625